产品中心Cell Resources
联系我们CONTACT US
- 400-999-210024小时服务热线
产品概述
名称 | Li-7 (人肝癌细胞) (STR鉴定正确) |
别称 | LI7; Li7; C-Li-7 |
种属 | 人 |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 | 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮 |
培养方案A(默认) |
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
|
推荐传代比例 | 1:2-1:4 |
推荐换液频率 | 2-3次/周 |
背景描述 | Li-7细胞是一株人肝癌细胞株,这株细胞建立于裸鼠体外移植瘤。 |
年龄(性别) | 男性;45岁 |
组织来源 | 肝 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 肝胆癌细胞 |
保藏机构 | RCB; RCB1941 TKG; TKG 0368 |
STR鉴定
-
STR位点信息
Amelogenin X CSF1PO 12 D2S1338 17,19 D3S1358 15,16 D5S818 9,11 D7S820 10,11 D8S1179 13,14 D13S317 11 D16S539 9 D18S51 16 D19S433 12,14 D21S11 30 FGA 20 PentaD 10 PentaE 5,19 TH01 7 TPOX 8,11 vWA 16,19 D6S1043 10,12 D12S391 22,24 D2S441 9.1,11 -
STR鉴定图
参考文献
-
5′-tiRNA-Gln inhibits hepatocellular carcinoma progression by repressing translation through the interaction with eukaryotic initiation factor 4A-I(2023/03/28)
作者:Chengdong Wu, Dekai Liu, Lufei Zhang
期刊:Frontiers of Medicine
影响因子 :8.100
-
CRHBP is degraded via autophagy and exerts anti-hepatocellular carcinoma effects by reducing cyclin B2 expression and dissociating cyclin B2-CDK1 complex(2022/01/27)
作者:Zhiwei Wang, Mingxing Li, Yuanfeng Liu
期刊:Cancer Gene Therapy
DOI:10.1038/s41417-021-00423-4
影响因子 :5.854
-
PRDM16 from hepatic stellate cells-derived extracellular vesicles promotes hepatocellular carcinoma progression(2023/11/15)
作者:Chen Sun, Wenwen Xu, Yunhong Xia
期刊:American Journal of Cancer Research
DOI:PMID:38058806
影响因子 :5.300
引用产品:CL-0139
-
Establishment of Replication Deficient Vesicular Stomatitis Virus for Studies of PEDV Spike-Mediated Cell Entry and Its Inhibition(2023/08/12)
作者:Huaye Luo, Lilei Lv, Jingxuan Yi
期刊:Microorganisms
DOI:10.3390/microorganisms11082075
影响因子 :4.500
-
ZNF131 facilitates the growth of hepatocellular carcinoma by acting as a transcriptional activator of SMC4 expression(2024/01/11)
作者:Meng Jin, Yang Mi, Fazhan Li
期刊:BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
DOI:10.1016/j.bbrc.2024.149515
影响因子 :3.100
引用产品:CL-0139
-
Silencing of keratin 15 impairs viability and mobility while facilitating the doxorubicin chemosensitivity by inactivating the β‑catenin pathway in liver cancer(2023/08/30)
作者:Junying Wang, Guangyu Zhu
期刊:Oncology Letters
影响因子 :2.900
引用产品:CL-0102 CL-0103 CL-0120 CL-0139 CL-0415 PB180120 PM150110 PM150210